IP Library Granted Patent US 12,672,822
Granted Patent B2
US 12,672,822 · App. 18/951,241 · Granted Jul 7, 2026

Therapy scoring for hemodynamic conditions

Inventors: Rachel June Smith (Irvine, CA); Zhongping Jian (Irvine, CA); Feras Al Hatib (Irvine, CA); Andrew Marino (Rowland Heights, CA); Sai Prasad Buddi (Costa Mesa, CA)
Assignee: Becton, Dickinson and Company
A61B5/4848A61B5/021A61B5/02405A61B5/029A61B5/4839A61B5/742G16H20/17G16H40/67G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,672,822
App. No.
18/951,241
Granted
Jul 7, 2026
Kind
B2
Abstract

A system for monitoring arterial pressure of a patient determines a score that is predictive of responsiveness of the patient to a therapy. Sensed hemodynamic data representative of an arterial pressure waveform of the patient are received by a hemodynamic monitor. Magnitude data and trend data are derived from the hemodynamic data. The score that is predictive of the responsiveness of the patient to the therapy is determined based on the magnitude data and the trend data of the hemodynamic parameter. A representation of the score is output.

Claims (46)

1 . A system for monitoring arterial pressure of a patient and determining one or more scores that are predictive of responsiveness of the patient to a corresponding therapy, the system comprising:

a hemodynamic sensor that produces sensed hemodynamic data representative of an arterial pressure waveform of the patient;

a system memory that stores hemodynamic therapy scoring software code;

a user interface; and

a hardware processor that is configured to execute the hemodynamic therapy scoring software code to:

derive, from the sensed hemodynamic data representative of the arterial pressure waveform of the patient, first magnitude data and first trend data of a first hemodynamic parameter selected from the group consisting of a stroke volume variation (SVV), a pulse pressure variation (PPV), a stroke volume (SV), and a stroke volume index (SVI), wherein the first hemodynamic parameter is indicative of a condition treatable by an intravenous delivery of a saline fluid to the patient;

derive, from the sensed hemodynamic data representative of the arterial pressure waveform of the patient, second magnitude data and second trend data of a second hemodynamic parameter selected from the group consisting of a systemic vascular resistance (SVR) and a systemic vascular resistance index (SVRI), wherein the second hemodynamic parameter is indicative of a condition treatable by an intravenous delivery of a vasopressor to the patient;

derive, from the sensed hemodynamic data representative of the arterial pressure waveform of the patient, third magnitude data and third trend data of a third hemodynamic parameter selected from the group consisting of a maximal rate of rise of arterial pressure (dP/dt max ), a cardiac output (CO), and a cardiac index (CI), wherein the third hemodynamic parameter is indicative of a condition treatable by an intravenous delivery of an inotrope to the patient;

determine a first magnitude sub-score based on the first magnitude data, a second magnitude sub-score based on the second magnitude data, and a third magnitude sub-score based on the third magnitude data;

determine a first trend sub-score based on the first trend data, a second trend sub-score based on the second trend data, and a third trend sub-score based on the third trend data;

determine a first score as a combination of the first magnitude sub-score and the first trend sub-score, a second score as a combination of the second magnitude sub-score and the second trend sub-score, and a third score as a combination of the third magnitude sub-score and the third trend sub-score; and

output, via the user interface, a representation of the first score that is predictive of responsiveness of the patient to the intravenous delivery of the saline fluid, a representation of the second score that is predictive of responsiveness of the patient to the intravenous delivery of the vasopressor, and a representation of the third score that is predictive of responsiveness of the patient to the intravenous delivery of the inotrope.

2 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the first score as the combination of the first magnitude sub-score and the first trend sub-score by determining the first score as a multiplicative product of the first magnitude sub-score and the first trend sub-score.

3 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the first magnitude sub-score as a normalized value ranging between a lower normalized threshold at a lower magnitude threshold of the first magnitude data of the first hemodynamic parameter and an upper normalized threshold at an upper magnitude threshold of the first magnitude data of the first hemodynamic parameter.

4 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the first trend data of the first hemodynamic parameter by determining a slope of a best-fit line of the first hemodynamic parameter associated with a defined time interval.

5 . The system of claim 4 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the first trend sub-score by normalizing the slope of the best-fit line of the first hemodynamic parameter to determine a normalized slope of the best-fit line of the first hemodynamic parameter associated with the defined time interval.

6 . The system of claim 5 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the first trend sub-score by applying a weighting factor to the normalized slope of the best-fit line of the first hemodynamic parameter to determine a weighted normalized slope of the best-fit line of the first hemodynamic parameter associated with the defined time interval.

7 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the first trend data of the first hemodynamic parameter by determining a plurality of slopes of a plurality of best-fit lines of the first hemodynamic parameter associated with a plurality of defined time intervals.

8 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the second score as the combination of the second magnitude sub-score and the second trend sub-score by determining the second score as a multiplicative product of the second magnitude sub-score and the second trend sub-score.

9 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the second magnitude sub-score as a normalized value ranging between a lower normalized threshold at a lower magnitude threshold of the second magnitude data of the second hemodynamic parameter and an upper normalized threshold at an upper magnitude threshold of the second magnitude data of the second hemodynamic parameter.

10 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the second trend data of the second hemodynamic parameter by determining a slope of a best-fit line of one or more best-fit lines of the second hemodynamic parameter associated with a defined time interval.

11 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the second trend data of the second hemodynamic parameter by determining a plurality of slopes of a plurality of best-fit lines of the second hemodynamic parameter associated with a plurality of defined time intervals.

12 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the third score as the combination of the third magnitude sub-score and the third trend sub-score by determining the third score as a multiplicative product of the third magnitude sub-score and the third trend sub-score.

13 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the third magnitude sub-score as a normalized value ranging between a lower normalized threshold at a lower magnitude threshold of the third magnitude data of the third hemodynamic parameter and an upper normalized threshold at an upper magnitude threshold of the third magnitude data of the third hemodynamic parameter.

14 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the third trend data of the third hemodynamic parameter by determining a slope of a best-fit line of one or more best-fit lines of the third hemodynamic parameter associated with a defined time interval.

15 . The system of claim 1 , wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the third trend data of the third hemodynamic parameter by determining a plurality of slopes of a plurality of best-fit lines of the third hemodynamic parameter associated with a plurality of defined time intervals.

16 . The system of claim 1 , wherein:

the first trend data of the first hemodynamic parameter is based on one or more first best fit lines, the second trend data of the second hemodynamic parameter is based on one or more second best fit lines, and the third trend data of the third hemodynamic parameter is based on one or more third best fit lines; and

the one or more first best fit lines, the one or more second best fit lines, and the one or more third best fit lines are determined using linear regression.

17 . A system for monitoring arterial pressure of a patient and determining one or more scores that are predictive of responsiveness of the patient to a corresponding therapy, the system comprising:

a hemodynamic sensor that produces sensed hemodynamic data representative of an arterial pressure waveform of the patient;

a system memory that stores hemodynamic therapy scoring software code;

a user interface; and

a hardware processor that is configured to execute the hemodynamic therapy scoring software code to:

derive, from the sensed hemodynamic data representative of the arterial pressure waveform of the patient:

first magnitude data and first trend data of a first hemodynamic parameter indicative of a condition treatable by an intravenous delivery of a saline fluid to the patient;

second magnitude data and second trend data of a second hemodynamic parameter indicative of a condition treatable by an intravenous delivery of a vasopressor to the patient; and

third magnitude data and third trend data of a third hemodynamic parameter indicative of a condition treatable by an intravenous delivery of an inotrope to the patient;

wherein the first hemodynamic parameter, the second hemodynamic parameter, and the third hemodynamic parameter are different from one another;

determine a first magnitude sub-score based on the first magnitude data, a second magnitude sub-score based on the second magnitude data, and a third magnitude sub-score based on the third magnitude data;

determine a first trend sub-score based on the first trend data, a second trend sub-score based on the second trend data, and a third trend sub-score based on the third trend data;

determine a first score as a combination of the first magnitude sub-score and the first trend sub-score, a second score as a combination of the second magnitude sub-score and the second trend sub-score, and a third score as a combination of the third magnitude sub-score and the third trend sub-score; and

output, via the user interface, a representation of the first score that is predictive of responsiveness of the patient to the intravenous delivery of the saline fluid, a representation of the second score that is predictive of responsiveness of the patient to the intravenous delivery of the vasopressor, and a representation of the third score that is predictive of responsiveness of the patient to the intravenous delivery of the inotrope.

18 . The system of claim 17 , wherein the first hemodynamic parameter is selected from the group consisting of a stroke volume variation (SVV), a pulse pressure variation (PPV), a stroke volume (SV), and a stroke volume index (SVI).

19 . The system of claim 17 , wherein the second hemodynamic parameter is selected from the group consisting of a systemic vascular resistance (SVR) and a systemic vascular resistance index (SVRI).

20 . The system of claim 17 , wherein the third hemodynamic parameter is selected from the group consisting of a maximal rate of rise of arterial pressure (dP/dt max ), a cardiac output (CO), and a cardiac index (CI).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2026
From: BD SWITZERLAND SARL
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 075604/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2026
From: EDWARDS LIFESCIENCES CORPORATION
To: BD SWITZERLAND SARL
Reel/Frame 075604/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2026
From: SMITH, RACHEL JUNE; JIAN, ZHONGPING; AL HATIB, FERAS; MARINO, ANDREW; BUDDI, SAI PRASAD
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 074709/0046 →
Continuity (3)
Continuation 16985937 · Aug 5, 2020
Provisional Application 62980585 · Feb 24, 2020
Related Publication 20250143637A1 · May 8, 2025
References Cited (94)
US 5482036A · Diab et al. · 1996 [cited by applicant]
US 5819226A · Gopinathan et al. · 1998 [cited by applicant]
US 7572230B2 · Neumann et al. · 2009 [cited by applicant]
US 8478389B1 · Brockway et al. · 2013 [cited by applicant]
US 9662028B2 · Vainoras et al. · 2017 [cited by applicant]
US 20030036685A1 · Goodman · 2003 [cited by applicant]
US 20030149453A1 · Kroll et al. · 2003 [cited by applicant]
US 20030167010A1 · Pinsky · 2003 [cited by applicant]
US 20050187796A1 · Rosenfeld et al. · 2005 [cited by applicant]
US 20080200775A1 · Lynn · 2008 [cited by applicant]
US 20080319332A1 · Sornmo et al. · 2008 [cited by applicant]
US 20110077532A1 · Kim et al. · 2011 [cited by applicant]
US 20110245631A1 · Genc · 2011 [cited by applicant]
US 20120271612A1 · Barsoum et al. · 2012 [cited by applicant]
US 20130023776A1 · Olde et al. · 2013 [cited by applicant]
US 20130096402A1 · Olde et al. · 2013 [cited by applicant]
US 20130204542A1 · Olde et al. · 2013 [cited by applicant]
US 20130262357A1 · Amarasingham et al. · 2013 [cited by applicant]
US 20140107433A1 · Wegerich · 2014 [cited by applicant]
US 20140107504A1 · Stapelfeldt et al. · 2014 [cited by applicant]
US 20140279754A1 · Barsoum et al. · 2014 [cited by applicant]
US 20140323885A1 · Genc et al. · 2014 [cited by applicant]
US 20140364750A1 · Brumfield et al. · 2014 [cited by applicant]
US 20150025329A1 · Amarasingham et al. · 2015 [cited by applicant]
US 20150065826A1 · Mulligan et al. · 2015 [cited by applicant]
US 20150116333A1 · Harper et al. · 2015 [cited by applicant]
US 20150150514A1 · Batchinsky et al. · 2015 [cited by applicant]
US 20150164437A1 · Mccombie et al. · 2015 [cited by applicant]
US 20150282717A1 · Mccombie et al. · 2015 [cited by applicant]
US 20150297143A1 · Rajan et al. · 2015 [cited by applicant]
US 20150347698A1 · Soni et al. · 2015 [cited by applicant]
US 20160012197A1 · Eromo et al. · 2016 [cited by applicant]
US 20160142894A1 · Papakonstantinou et al. · 2016 [cited by applicant]
US 20160143596A1 · Bhattacharya et al. · 2016 [cited by applicant]
US 20160378943A1 · VallÉe · 2016 [cited by applicant]
US 20170076211A1 · Kusumura et al. · 2017 [cited by applicant]
US 20170116497A1 · Georgescu et al. · 2017 [cited by applicant]
US 20170235917A1 · Bighamian et al. · 2017 [cited by applicant]
US 20170308981A1 · Razavian et al. · 2017 [cited by applicant]
US 20180008205A1 · Al Hatib · 2018 [cited by examiner]
US 20180020989A1 · Al et al. · 2018 [cited by applicant]
US 20180025290A1 · Al Hatib et al. · 2018 [cited by applicant]
US 20180028076A1 · Al Hatib · 2018 [cited by examiner]
US 20180182492A1 · Yamashita · 2018 [cited by applicant]
US 20180184901A1 · Akmandor · 2018 [cited by examiner]
US 20180322951A1 · Vairavan et al. · 2018 [cited by applicant]
US 20190307337A1 · Little et al. · 2019 [cited by applicant]
US 20200260965A1 · Munoz et al. · 2020 [cited by applicant]
US 20210259629A1 · Smith et al. · 2021 [cited by applicant]
US 20220395236A1 · Buddi et al. · 2022 [cited by applicant]
US 20220400965A1 · Schneider et al. · 2022 [cited by applicant]
US 20230380697A1 · Buddi et al. · 2023 [cited by applicant]
CN 1652718A · 2005 [cited by applicant]
EP 2679256A1 · 2014 [cited by applicant]
EP 2730302A1 · 2014 [cited by applicant]
JP 2006318162A · 2006 [cited by applicant]
JP 2008506472A · 2008 [cited by applicant]
JP 2011512929A · 2011 [cited by applicant]
JP 2014511719A · 2014 [cited by applicant]
JP 2017060571A · 2017 [cited by applicant]
JP 2019516477A · 2019 [cited by applicant]
KR 20090049709A · 2009 [cited by applicant]
WO 0241771A1 · 2002 [cited by applicant]
WO WO2014116276A1 · 2014 [cited by examiner]
WO WO2016022989A2 · 2016 [cited by examiner]
Chen, X. et al., Forecasting Acute Hypotensive Episodes in Intensive Care Patients Based on a Peripheral Arterial Blood Pressure Waveform, Computers in Cardiology 2009; 36:545-548. [cited by applicant]
Chiarugi, F., Predicting the Occurrence of Acute Hypotensive Episodes: The PhysioNet Challenge; Computers in Cardiology 2009; 36:621-624. [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 21703571.6, dated Apr. 20, 2023, 6 pages. [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 21703571.6, dated Dec. 11, 2024, 10 pages. [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 21703571.6, dated Feb. 22, 2024, 8 pages. [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 21703571.6, dated Oct. 6, 2023, 6 pages. [cited by applicant]
Fournier, Pa, et al., Acute Hypotension Episode Prediction Using Information Divergence for a Feature Selection, and Non-Parametric Methods for Classification; Computers in Cardiology 2009; 36:625-628. [cited by applicant]
Hastie, Trevor, Robert Tibshirani, and Jerome Friedman. The elements of statistical learning: data mining, inference, and prediction. Chapters 3 and 11. Springer Science & Business Media, 2009. (Year: 2009). [cited by applicant]
Hatib F, Jian Z, Buddi S, Lee C, Settels J, Sibert K, Rinehart J, Cannesson M. Machine-learning Algorithm to Predict Hypotension Based on High-fidelity Arterial Pressure Waveform Analysis. Anesthesiology. Oct. 2018; 129… [cited by applicant]
Hayn, D., A Biosignal Analysis Applied for Developing an Algorithm Predicting Critical Situations of High Risk Cardiac Patients by Hemodynamic Monitoring; Computers in Cardiology 2009; 36: 629-632. [cited by applicant]
Henriques, Jh et al., Prediction of Acute Hypotensive Episodes Using Neural Network Multi-models; Computers in Cardiology 2009; 36-549-552. [cited by applicant]
Ho, Tct et al., Utilizing Histogram to Identify Patients Using Pressors for Acute Hypotension, Computers in Cardiology 2009; 36:797-800. [cited by applicant]
International Preliminary Report on Patentability for PCT Application No. PCT/US2021/012788, dated Sep. 9, 2022, 10 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2021/012788, dated May 3, 2021, 11 pages. [cited by applicant]
Janghorbani et al., “Prediction of Acute Hypotension Episodes Using Logistic Regression Model and Support Vector Machine: A Comparative Study”, IEEE, 19th Iranian Conference on Electrical Engineering (Year: 2011). [cited by applicant]
Jin, K. et al., Smooting and Discriminating MAP Data; Computers in Cardiology 2009; 36: 633-636. [cited by applicant]
Jousset, F., Computers in Cardiology/Physionet Challenge 2009: Predicting Acute Hypotensive Episodes, 2009; 36:637-640. [cited by applicant]
Langley, P., et al., Predicting Acute Hypotensive Episodes From Mean Arterial Pressure; Computers in Cardiology 2009; 36: 553-556. [cited by applicant]
Liu et al., “Utility of Vital Signs, Heart Rate Variability and Complexity, and Machine Learning for Identifying the Need for Lifesaving Interventions in Trauma Patients,” SHOCK, vol. 42, No. 2, pp. 108-114, 2014 (Year:… [cited by applicant]
Maldonado, Sebastian, and Richard Weber. “A wrapper method for feature selection using support vector machines.” Information Sciences 179, 13 (2009): 2208-2217. (Year: 2009). [cited by applicant]
Malik, Marek, et al. “Heart rate variability: Standards of measurement, physiological interpretation, and clinical use.” European heartjournal 17.3 (1996): 354-381. (Year: 1996). [cited by applicant]
Mneimneh, Ma, et al., A Rule-Based Approach for the Prediction of Acute Hypotensive Episodes; Computers in Cardiology 2009; 36: 557-560. [cited by applicant]
Moody, GB et al.; Predicting Acute Hypotensive Episodes: The 10th Annual PhysioNet/Computers in Cardiology Challenge, 2009; 36:541-544. [cited by applicant]
Notice of Reasons for Rejection for Japanese Patent Application No. 2022-550828, dated Dec. 16, 2024, 5 pages. [cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2022-550828, dated Aug. 26, 2024, 8 pages. [cited by applicant]
Pinsky, M. R., “Protocolized Cardiovascular Management Based on Ventribular-arterial Coupling,” Functional Hemodynamic Monitoring pp. 381-395, Jan. 2005. [cited by applicant]
Sannino, Giovanna, et al. “To what extent is it possible to predict fails due to standing hypotension by using HRV and wearable devices? Study design and preliminary results from a proof-of-concept study.” International… [cited by applicant]
Search Report by Japanese Patent Office for Japanese Patent Application No. 2022-550828, dated Jan. 8, 2021, 29 pages. [cited by applicant]
First Chinese Office Action for Chinese Patent Application No. 2021800137549, dated Apr. 14, 2026, 16 pages. [cited by applicant]